Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver

Bone Marrow Transplantation

Volumn 35, Issue 1, 2005, Pages 85-89

  Turchin, A ^a   Wiebe, D A ^b   Seely, E W ^a   Graham, T ^c   Longo, W ^b   Soiffer, R ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Graft versus host disease; Hypercholesterolemia; Hyperlipidemia; Lipoprotein X

Indexed keywords

CHOLESTEROL; COLESTIPOL; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN; LIPOPROTEIN X; MYCOPHENOLIC ACID; PREDNISONE; PROTEIN X; RAPAMYCIN; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DIABETES MELLITUS; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPONATREMIA; INFECTION; LIVER DISEASE; LIVER FAILURE; LUNG TUMOR; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA DISEASE; THROMBOEMBOLISM;

ADULT; BONE MARROW TRANSPLANTATION; CHOLESTASIS; CHOLESTEROL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN-X; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 11844255681     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704739     Document Type: Article

References (32)

1. Sprecher DL, Schaefer EJ, Kent KM et al. Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 1984; 54: 20-30.
2. Connelly PW, Hegele RA. Hepatic lipase deficiency. Crit Rev Clin Lab Sci 1998; 35: 547-572.
3. McIntyre N, Harry DS, Pearson AJG. The hypercholesterolaemia of obstructive jaundice. Gut 1975; 16: 379-391.
4. Dickson ER, Fleming CR, Ludwig J. Primary biliary cirrhosis. In: Popper H, Schaffner F (eds). Progress in Liver Diseases, Vol. 6 Grune & Stratton: New York, 1979, pp 487-528.
5. Coetzee GA, van der Westhuyzen DR, Berger GM et al. Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia. Arteriosclerosis 1982; 2: 303-311.
6. Rosenson RS, Baker AL, Chow MJ et al. Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 1990; 98: 1351-1357.
7. Illingworth DR. How effective is drug therapy in heterozygous familial hypercholesterolemia? Am J Cardiol 1993; 72: 54D-58D.
8. Malloy MJ, Kane JP, Kunitake ST et al. Complementarity of colestipol, niacin, lovastatin in treatment of severe familial hypercholesterolemia. Ann Intern Med 1987; 107: 616-623.
9. Gordon BR, Kelsey SF, Bilheimer DW et al. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group. Am J Cardiol 1992; 70: 1010-1016.
10. Przepiorka D, Anderlini P, Saliba R et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695-1700.
11. Coakley JC, Vervaart PP, McKay MRG. Factitious hyponatremia in a patient with cholestatic jaundice following bone marrow transplantation. Pathology 1986; 18: 158-159.
12. Toren A, Nagler A. Solitary pulmonary cholesteroloma, multiple xanthelasmas, lipemia retinalis complicating hypercholesterolemia after bone marrow transplantation. Bone Marrow Transplant 1996; 18: 457-459.
13. Turchin A, Seifter JL, Seely EW. Mind the gap. N Engl J Med 2003; 349: 1463-1466.
14. Huseby NE. Multiple forms of serum gamma-glutamyltransferase. Association of the enzyme with lipoproteins. Clin Chim Acta 1982; 124: 103-112.
15. Miller J. Dyslipoproteinaemia of liver disease. Bail Clin Endocrinol Metab 1990; 4: 807-831.
16. Van Hoof VO, Lepoutre LG, Hoylaerts MF et al. Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin Chem 1988; 34: 1857-1862.
17. Wolf P. Clinical significance of serum high-molecular-mass alkaline phosphatase, alkaline phosphatase-lipoprotein-X complex, intestinal variant alkaline phosphatase. J Clin Lab Anal 1994; 8 172-176.
18. Seidel D, Alaupovic P, Furman RH. A lipoprotein characterizing obstructive jaundice. Method for quantitative separation, identification of lipoproteins in jaundiced subjects. J Clin Invest 1969; 48: 1211-1223.
19. Kuster GM, Drexel H, Bleisch JA et al. Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 1994; 57: 1479-1483.
20. Satterthwaite R, Aswad S, Sunga V et al. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation 1998; 65: 446-449.
21. Chueh SC, Kahan BD. Dyslipidemia in renal transplant recipients treated with a sirolimus, cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, prognosis. Transplantation 2003; 76: 375-382.
22. Morrisett JD, Abdel-Fattah G, Hoogeveen R et al. Effects of sirolimus on plasma lipids, lipoprotein levels, fatty acid metabolism in renal transplant patients. J Lipid Res 2002; 43 1170-1180.
23. Roche Laboratories. Cellcept® (mycophenolate mofetil) Complete Product Information (online), 2004 (cited October 14, 2004). Available from: URL: http//www.rocheusa.com/products/cellcept/pi.pdf.
24. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 2000; 16: 505-511.
25. Al-Fiar FZ, Colwill R, Lipton JH et al. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant 1997; 19: 1019-1022.
26. Kutty KM, Bryant DG, Farid NR. Serum lipids in hypothyroidism - a re-evaluation. J Clin Endocrinol, Metab 1978; 46: 55-56.
27. O'Brien T, Dinneen SF, O'Brien PC et al. Hyperlipidemia in patients with primary, secondary hypothyroidism. Mayo Clin Proc 1993; 68: 860-866.
28. Glomset JA, Nichols AV, Norum KR et al. Plasma lipoproteins in familial lecithin-cholesterol acyltransferase deficiency. J Clin Invest 1973; 52: 1078-1092.
29. Strasser SI, Shulman HM, McDonald GB. Cholestasis after hematopoietic cell transplantation. Clin Liver Dis 1999; 3: 651-668.
30. Lewis III JL. Water, electrolyte, mineral and acid-base metabolism. In: Beers MH, Berkow R (eds). The Merck Manual of Diagnosis and Therapy. Merck Research Laboratories: Whitehouse Station, NJ, 1999, pp 120-164.
31. Robinson AG, Verbalis JG. Posterior pituitary gland. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds). Williams Textbook of Endocrinology. W.B. Saunders Company: St Louis, 2002, pp 281-329.
32. Fukagawa M, Kurokawa K, Papadakis MA. Fluid and electrolyte disorders. In: Tierney Jr LM, McPhee SJ, Papadakis MA (eds). Current Medical Diagnosis and Treatment. The McGraw-Hill Companies, Inc.: New York, 2003, pp 839-866.